FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, allergology, and can be used for estimating allergen-specific immunotherapy (ASIT) response rate in pollen-induced conjunctivitis. That is ensured by a provocative conjunctival test (PCT) that precedes the ASIT. 2-3 months after the ASIT, the PCT is administered again. The therapeutic effect is considered to be effective if observing an increasing threshold PCT dose as compared with an initial value before treatment in two and more times.
EFFECT: estimation of the ASIT response rate in specified mode with using said estimation criterion allows predicting the severity of clinical symptoms and considering possibility of antiallergic preparations application frequency reduction in aggravation of eye disease associated with pollinosis.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT ATOPIC ALLERGIC DISEASES | 0 |
|
SU1695925A1 |
| METHOD OF TREATING CHRONIC RECURRENT ALLERGIC DISEASES OF NASAL MUCOSA AND PARANASAL SINUSES BY ENDONASAL AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2411048C1 |
| METHOD OF TREATING ALLERGIC DISEASES BY AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2395305C1 |
| METHOD FOR ASSESSMENT OF EFFICIENCY OF ALLERGEN-SPECIFIC IMMUNOTHERAPY IN ALLERGIC RHINITIS | 2019 |
|
RU2700788C1 |
| METHOD OF TREATMENT OF CHILDREN WITH POLLINOSIS | 1998 |
|
RU2149645C1 |
| METHOD OF EFFICIENCY CONTROL FOR POLLINOSIS SPECIFIC IMMUNOTHERAPY | 2007 |
|
RU2370774C2 |
| METHOD OF SUBLINGUAL ALLERGEN-SPECIFIC IMMUNOTHERAPY (SASI) OF POLLINOSIS WITH HYPOSENSITIZATION AGENT | 2019 |
|
RU2725633C1 |
| METHOD OF TREATMENT OF ALLERGIC DISEASES OF CHILDREN | 0 |
|
SU1261673A1 |
| METHOD OF PREDICTING DEVELOPMENT OF POLLEN BRONCHIAL ASTHMA | 2010 |
|
RU2433408C1 |
| METHOD FOR PREDICTION OF POLLEN BRONCHIAL ASTHMA | 2010 |
|
RU2441242C1 |
